ReviewPhytotherapy research : PTR2026
Evaluating the Safety of Ashwagandha as a Food Additive: A Focus on Reproductive, Thyroid, and Immune System Effects.
Review in Phytotherapy research : PTR, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Ashwagandha ( Withania somnifera (L.) Dunal), a perennial plant of the genus Withania in the Solanaceae family, is widely used in traditional Indian medicine. In recent years, its use as a dietary supplement has gained increasing popularity. However, concerns regarding its safety have attracted significant attention. This review comprehensively examines the effects of Ashwagandha on the female and male reproductive systems, thyroid hormones, acetylcholinesterase activity, the immune system, and the liver. By analyzing relevant research studies and case reports, it aims to thoroughly evaluate the safety of Ashwagandha as a food additive and provide a scientific basis for its rational use. The findings indicate that Ashwagandha poses significant risks to specific populations, such as pregnant women, patients with thyroid disorders, and individuals with liver or kidney dysfunction. Furthermore, multiple cases of liver damage have been reported, raising concerns about its long-term safety. It is recommended to restrict the use of Ashwagandha as a food additive, enhance label warnings, and conduct more high-quality studies to clarify its mechanisms of action and safety thresholds, thereby ensuring its responsible application in the dietary supplement field.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.